Navigation Links
Many Patients With Heart Attack Delay Hospital Care
Date:11/8/2010

By Amanda Gardner
HealthDay Reporter

MONDAY, Nov. 8 (HealthDay News) -- The time it takes for a patient to get to an emergency room when experiencing the symptoms of a heart attack have remained stubbornly high for the past decade, despite efforts to fix that, researchers report.

A new study in the Nov. 8 issue of Archives of Internal Medicine found that it took heart attack patients an average of 2.6 hours to get to the hospital after first noticing symptoms -- this despite education efforts to get people to call for help or leave for the hospital within five minutes of chest pain, jaw pain, shortness of breath or other symptoms.

Progress has been made in cutting system delays -- meaning what happens after a patient enters into medical care -- with "door-to-balloon" (such as angioplasty) times now well below 90 minutes, and sometimes as low as 50 or 60 minutes. Time is especially critical for patients with a type of heart attack called ST-segment elevation myocardial infarction (STEMI), which tends to be the more severe form of heart attack.

Previous research has shown that the time from onset of symptoms to arriving at the hospital for STEMI patients is about 114 minutes, or less than two hours, the study authors said.

The new study looked at non-STEMI patients.

"People have put in a lot of effort to reduce the time from the paramedic to getting to the hospital and into the cardiac cath [catheterization] lab where you open up the blocked vessels, and there's been great success with that," said Dr. Frederick Ling, director of the cardiac catheterization laboratory at the University of Rochester Medical Center in Rochester, N.Y. "The issue is that there really has to be a lot more focus now on the patient side, but the patient part of it is much harder to do."

Study lead author Dr. Henry H. Ting, an interventional cardiologist with the Mayo Clinic in Rochester, Minn., said: "A heart attack starts when you first develop symptoms, not with the first medical contact. There's an upstream component when a patient develops symptoms before they decide to call 911 or come into the hospital."

Ting and his colleagues analyzed data on more than 104,000 patients who had arrived at one of 568 hospitals with a non-STEMI heart attack from the beginning of 2001 to the end of 2006. This information was included in a national registry funded by several pharmaceutical companies, although this study was not funded by those firms.

The median delay time of 2.6 hours did not budge during the six-year time period. Fifty-nine percent of patients took more than two hours to get to the hospital while 11 percent took 12 hours after symptoms started.

Women, along with people who were older or non-white, who had diabetes or were current smokers were the least likely to seek timely care.

And patients who arrived at the hospital during weekday and weekend nights -- between 12 a.m. and 8 a.m. -- had 25 percent shorter delay times than patients who arrived between 8 a.m. and 4 p.m. on weekdays, the investigators found.

But, the delays didn't seem to be associated with mortality, at least with the non-STEMI patients in the study.

The study findings suggest that initial assumptions about the cause of the delays -- that patients simply didn't know they were having a heart attack -- may be wrong, the study authors said.

"There may be other reasons why patients delay," Ting said.

Previous studies have found that both an individual's trust in the health-care system and their insurance status have influenced when they call for help.

"It may not be, 'I don't know what the symptoms are,' but more, 'Do I trust the system?' and 'Can I pay for it?'" Ting said.

Another study, this one published in the November issue of Archives of Neurology, found that patients with an ischemic stroke who receive and respond to the clot-dissolving drug recombinant tissue plasminogen activator (rt-PA) within an hour of their stroke tend to fare much better three months later.

But not all patients respond to rt-PA, and those patients may be candidates for a different approach that uses rt-PA followed by other clot-busting therapies.

The new findings suggest that using a simple measure of neurological function at a patient's bedside may help decide which patients are benefiting from rt-PA therapy and which ones need additional medical measures, stated the study authors, from Assistance-Publique-Hopitaux in Paris, France.

More information

The American Heart Association has more on how to recognize the symptoms of a heart attack.

SOURCES: Henry H. Ting, M.D., interventional cardiologist, Mayo Clinic, Rochester, Minn.; Frederick Ling, M.D., associate professor of medicine, and director, Cardiac Catheterization Laboratory, University of Rochester Medical Center, Rochester, N.Y.; Nov. 8, 2010, Archives of Internal Medicine; November 2010, Archives of Neurology


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients
2. Real-time physician electronic alerts reduce unnecessary blood testing in elderly patients
3. Anti-Delirium Drug May Harm Critically Ill Patients
4. Insufficient vitamin D levels in CLL patients linked to cancer progression and death
5. Experts issue recommendations for treatment of post-bariatric surgery patients
6. Combining radiation therapy, chemotherapy safely treats head and neck cancer patients
7. Patients Who Swallow Foreign Objects a Costly Burden to Health Care
8. Prognostic markers for prostate cancer patients who receive radiation after surgery
9. Study Casts Doubt on Hospice Admission Criteria for Patients With Dementia
10. Program May Help Prevent Falls in Hospitalized Patients
11. Long Hours Put Surgeons, Patients at Risk, Study Suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... AZ (PRWEB) , ... December 08, 2016 , ... ... firm with offices that serve communities in and around the greater Phoenix metropolitan ... the Homeless Youth Connection. , The mission of the Homeless Youth Connection is ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a family owned insurance ... around the Hancock County area, is announcing the launch of a charity effort aimed ... Hancock County Food Pantry has worked for more than 30 years to meet the ...
(Date:12/8/2016)... ... 08, 2016 , ... Bill Mull Agencies, a Wichita-based firm ... around central Kansas, is joining the Youth Horizons organization for a charity event ... in Wichita, Youth Horizons works to empower area children from unstable, troubled, or ...
(Date:12/7/2016)... Washington,DC (PRWEB) , ... December 07, 2016 , ... ... Forum (NYLF): Medicine will have the unique opportunity to get hands-on experience ... gives high school students an immersive experience to gain invaluable, real-life medical skills ...
(Date:12/7/2016)... ... ... Kenall Manufacturing, a leader in sealed healthcare lighting for more than 30 years, ... LED luminaire that meets the needs of everyone in the patient room by delivering ... A 2’ x 4’ model features four modes: reading, ambient, standard and high output ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Hanson Research, an innovative leader ... and diffusion testing instruments for the pharmaceutical industry, ... Instruments, Inc. ("Teledyne"). The move is designed to ... testing instruments, as well as expand resources for ... products and services. Logo - http://photos.prnewswire.com/prnh/20161208/446988LOGO ...
(Date:12/8/2016)... Augmedix, the nation,s leading smartglass-based physician ... a $23 million strategic round of funding from ... seeks to rehumanize the physician patient relationship by ... documentation. The Augmedix core offering is a Google ... 3 hours of mandated charting and documentation each ...
(Date:12/8/2016)... -- CANTEL MEDICAL CORP. (NYSE: CMD ) reported ... diluted share, on a 22.1% increase in sales to a ... This compares with net income of $14,254,000, or $0.34 per ... ended October 31, 2015. Non-GAAP net income ... to $21,323,000, or $0.51 per diluted share, compared with non-GAAP ...
Breaking Medicine Technology: